IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,608,919 | +8.1% | 35,470 | -2.2% | 0.09% | +11.2% |
| Q2 2023 | $1,488,733 | +14.4% | 36,284 | -0.3% | 0.08% | 0.0% |
| Q1 2023 | $1,301,258 | +117.4% | 36,409 | +129.8% | 0.08% | +105.1% |
| Q4 2022 | $598,466 | -12.6% | 15,845 | +2.4% | 0.04% | -20.4% |
| Q3 2022 | $685,000 | +14.2% | 15,477 | -4.5% | 0.05% | +28.9% |
| Q2 2022 | $600,000 | -8.0% | 16,203 | -7.9% | 0.04% | +40.7% |
| Q1 2022 | $652,000 | +10.3% | 17,592 | -9.4% | 0.03% | +42.1% |
| Q4 2021 | $591,000 | -23.0% | 19,417 | -15.2% | 0.02% | -26.9% |
| Q3 2021 | $768,000 | -19.9% | 22,891 | -4.9% | 0.03% | -18.8% |
| Q2 2021 | $959,000 | -14.0% | 24,058 | -3.0% | 0.03% | -25.6% |
| Q1 2021 | $1,115,000 | -30.8% | 24,797 | -13.0% | 0.04% | -38.6% |
| Q4 2020 | $1,611,000 | +30.8% | 28,489 | +9.7% | 0.07% | +11.1% |
| Q3 2020 | $1,232,000 | -25.6% | 25,969 | -7.6% | 0.06% | -31.5% |
| Q2 2020 | $1,657,000 | +45.7% | 28,096 | +16.8% | 0.09% | +8.2% |
| Q1 2020 | $1,137,000 | -42.7% | 24,051 | -26.7% | 0.08% | -1.2% |
| Q4 2019 | $1,983,000 | +12.5% | 32,824 | +11.6% | 0.09% | -3.4% |
| Q3 2019 | $1,763,000 | -20.7% | 29,425 | -14.9% | 0.09% | -15.2% |
| Q2 2019 | $2,222,000 | -28.6% | 34,567 | -9.8% | 0.10% | -30.0% |
| Q1 2019 | $3,111,000 | +52.3% | 38,329 | +1.4% | 0.15% | +19.0% |
| Q4 2018 | $2,043,000 | -15.6% | 37,785 | -19.5% | 0.13% | +37.0% |
| Q3 2018 | $2,420,000 | +48.9% | 46,922 | +20.3% | 0.09% | +41.5% |
| Q2 2018 | $1,625,000 | -10.9% | 38,988 | -5.7% | 0.06% | -11.0% |
| Q1 2018 | $1,823,000 | -20.8% | 41,357 | -9.6% | 0.07% | -18.0% |
| Q4 2017 | $2,302,000 | -11.8% | 45,757 | -11.1% | 0.09% | -18.3% |
| Q3 2017 | $2,610,000 | +8.5% | 51,480 | +8.9% | 0.11% | 0.0% |
| Q2 2017 | $2,405,000 | +21.0% | 47,274 | -4.4% | 0.11% | +22.5% |
| Q1 2017 | $1,987,000 | -22.4% | 49,430 | -7.7% | 0.09% | -24.6% |
| Q4 2016 | $2,560,000 | +12.8% | 53,531 | -13.6% | 0.12% | +9.3% |
| Q3 2016 | $2,269,000 | +49.6% | 61,932 | -4.9% | 0.11% | +45.9% |
| Q2 2016 | $1,517,000 | -44.7% | 65,125 | -3.9% | 0.07% | -47.9% |
| Q1 2016 | $2,744,000 | -47.5% | 67,744 | -19.7% | 0.14% | -42.7% |
| Q4 2015 | $5,223,000 | – | 84,334 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |